DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result

A Nowak, P Kok, W Lesterhuis, B Hughes, C Brown, S Kao, D Karikios, T John, N Pavlakis, K O'Byrne, S Yip, W Lam, K Briscoe, C Karapetis, M Stockler